AstraZeneca sees higher 2022 sales, but COVID boost waning Excelsio Media - comentarios AstraZeneca forecast higher 2022 sales and raised its annual dividend for the first time in a decade, but warned that the boost from COVID-19 product… More →
AstraZeneca sees higher 2022 sales, but COVID boost waning Excelsio Media - comentarios AstraZeneca forecast higher 2022 sales and raised its annual dividend for the first time in a decade, but warned that the boost from COVID-19 product… More →
AstraZeneca seeks U.S. approval for new COVID treatment Excelsio Media - comentarios AstraZeneca has requested emergency use authorization from U.S. regulators for its new treatment to prevent COVID-19 for people who respond poorly to… More →
AstraZeneca seeks U.S. approval for new COVID treatment Excelsio Media - comentarios AstraZeneca has requested emergency use authorization from U.S. regulators for its new treatment to prevent COVID-19 for people who respond poorly to… More →
AstraZeneca settles vaccines dispute with EU Excelsio Media - comentarios AstraZeneca and the European Commission have reached a settlement on the delivery of pending COVID-19 vaccine doses by the drugmaker, ending a row ab… More →
AstraZeneca settles vaccines dispute with EU Excelsio Media - comentarios AstraZeneca and the European Commission have reached a settlement on the delivery of pending COVID-19 vaccine doses by the drugmaker, ending a row ab… More →
Mixed AstraZeneca Pfizer shot boosts COVID antibody level, study says Excelsio Media - comentarios A mixed vaccination of first AstraZeneca and then a Pfizer COVID-19 shot boosted neutralizing antibody levels by six times compared with two AstraZen… More →
Mixed AstraZeneca Pfizer shot boosts COVID antibody level, study says Excelsio Media - comentarios A mixed vaccination of first AstraZeneca and then a Pfizer COVID-19 shot boosted neutralizing antibody levels by six times compared with two AstraZen… More →
AstraZeneca, Pfizer vaccines effective against Delta COVID-19 variants: study Excelsio Media - comentarios COVID-19 vaccines made by AstraZeneca and the Pfizer-BioNTech alliance remain broadly effective against Delta and Kappa variants of the COVID-19 caus… More →
AstraZeneca, Pfizer vaccines effective against Delta COVID-19 variants: study Excelsio Media - comentarios COVID-19 vaccines made by AstraZeneca and the Pfizer-BioNTech alliance remain broadly effective against Delta and Kappa variants of the COVID-19 caus… More →
Canadian PM Trudeau receives first dose of AstraZeneca's COVID-19 vaccine Excelsio Media - comentarios While holding the hand of his wife Sophie Gregoire Trudeau, Canadian Prime Minister Justin Trudeau on Friday received his first dose of AstraZeneca’s… More →
Canadian PM Trudeau receives first dose of AstraZeneca's COVID-19 vaccine Excelsio Media - comentarios While holding the hand of his wife Sophie Gregoire Trudeau, Canadian Prime Minister Justin Trudeau on Friday received his first dose of AstraZeneca’s… More →
Denmark ditches AstraZeneca's COVID-19 vaccine Excelsio Media - comentarios Denmark became the first country to stop using AstraZeneca’s COVID-19 vaccine altogether over a potential link to a rare but serious form of blood cl… More →
Denmark ditches AstraZeneca's COVID-19 vaccine Excelsio Media - comentarios Denmark became the first country to stop using AstraZeneca’s COVID-19 vaccine altogether over a potential link to a rare but serious form of blood cl… More →
AstraZeneca woes grow as more countries halt shots Excelsio Media - comentarios Australia and the Philippines limited use of AstraZeneca's COVID-19 vaccine on Thursday, while the African Union dropped plans to buy the shot, d… More →
AstraZeneca woes grow as more countries halt shots Excelsio Media - comentarios Australia and the Philippines limited use of AstraZeneca's COVID-19 vaccine on Thursday, while the African Union dropped plans to buy the shot, d… More →
Britain advises alternative to AstraZeneca for under-30s Excelsio Media - comentarios Britain should give an alternative to AstraZeneca's COVID-19 vaccine to under 30s where possible due to a rare side effect of blood clots in the … More →
Britain advises alternative to AstraZeneca for under-30s Excelsio Media - comentarios Britain should give an alternative to AstraZeneca's COVID-19 vaccine to under 30s where possible due to a rare side effect of blood clots in the … More →
U.S. ousts AstraZeneca from factory, puts J&J in charge Excelsio Media - comentarios The U.S. has put Johnson & Johnson in charge of a plant that ruined 15 million doses of its COVID-19 vaccine and stopped British drugmaker AstraZ… More →
U.S. ousts AstraZeneca from factory, puts J&J in charge Excelsio Media - comentarios The U.S. has put Johnson & Johnson in charge of a plant that ruined 15 million doses of its COVID-19 vaccine and stopped British drugmaker AstraZ… More →
AstraZeneca report says vaccine 76% effective Excelsio Media - comentarios AstraZeneca's said its COVID-19 vaccine was 76% effective in a new analysis of its U.S. trial - only a tad lower than the level in an earlier rep… More →
AstraZeneca report says vaccine 76% effective Excelsio Media - comentarios AstraZeneca's said its COVID-19 vaccine was 76% effective in a new analysis of its U.S. trial - only a tad lower than the level in an earlier rep… More →
AstraZeneca shots resume in Europe but some wait Excelsio Media - comentarios Europe pushed to get its COVID-19 vaccination drive back on track on Friday after regulators gave it the nod. But it was a mixed picture, with some c… More →
AstraZeneca shots resume in Europe but some wait Excelsio Media - comentarios Europe pushed to get its COVID-19 vaccination drive back on track on Friday after regulators gave it the nod. But it was a mixed picture, with some c… More →
Why European nations are suspending use of the AstraZeneca COVID vaccine Excelsio Media - comentarios A growing number of European nations are suspending use of the AstraZeneca COVID vaccine, one of three on the continent, after reports of blood clots… More →
Why European nations are suspending use of the AstraZeneca COVID vaccine Excelsio Media - comentarios A growing number of European nations are suspending use of the AstraZeneca COVID vaccine, one of three on the continent, after reports of blood clots… More →
Oxford-AstraZeneca Covid vaccine not linked to blood clots: WHO Excelsio Media - comentarios The World Health Organization (WHO) has said the Oxford-AstraZeneca vaccine is safe to use and not linked to increased risk of blood clots. More →
Oxford-AstraZeneca Covid vaccine not linked to blood clots: WHO Excelsio Media - comentarios The World Health Organization (WHO) has said the Oxford-AstraZeneca vaccine is safe to use and not linked to increased risk of blood clots. More →
Scientifically safe but Astrazeneca skeptics remain Excelsio Media - comentarios Despite multiple scientific studies saying the COVID-19 vaccine manufactured by AstraZeneca it is safe and effective, some residents in Europe are tu… More →
Scientifically safe but Astrazeneca skeptics remain Excelsio Media - comentarios Despite multiple scientific studies saying the COVID-19 vaccine manufactured by AstraZeneca it is safe and effective, some residents in Europe are tu… More →
Oxford COVID shot 'less effective on South Africa variant' Excelsio Media - comentarios AstraZeneca said that its vaccine developed with the University of Oxford appeared to offer limited protection against mild disease caused by the Sou… More →
Oxford COVID shot 'less effective on South Africa variant' Excelsio Media - comentarios AstraZeneca said that its vaccine developed with the University of Oxford appeared to offer limited protection against mild disease caused by the Sou… More →
AstraZeneca seeks to supply 2 million vaccines a week in the UK Excelsio Media - comentarios About 2 million doses of COVID-19 vaccine developed by Oxford University and AstraZeneca are set to be supplied every week by the middle of January i… More →
AstraZeneca seeks to supply 2 million vaccines a week in the UK Excelsio Media - comentarios About 2 million doses of COVID-19 vaccine developed by Oxford University and AstraZeneca are set to be supplied every week by the middle of January i… More →
AstraZeneca shares dip after $39 bln Alexion deal Excelsio Media - comentarios AstraZeneca shares fell on Monday, as investors moved to price in the British drugmaker's $39 billion deal for U.S. biotech firm Alexion Pharmace… More →
AstraZeneca shares dip after $39 bln Alexion deal Excelsio Media - comentarios AstraZeneca shares fell on Monday, as investors moved to price in the British drugmaker's $39 billion deal for U.S. biotech firm Alexion Pharmace… More →
Britain presses on with AstraZeneca vaccine Excelsio Media - comentarios Britain gave AstraZeneca's COVID-19 vaccine a vote of confidence, when it asked its regulator to assess it for a rollout, after experts raised qu… More →
Britain presses on with AstraZeneca vaccine Excelsio Media - comentarios Britain gave AstraZeneca's COVID-19 vaccine a vote of confidence, when it asked its regulator to assess it for a rollout, after experts raised qu… More →
J&J, AstraZeneca resume trials of COVID-19 vaccines Excelsio Media - comentarios AstraZeneca has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to r… More →
J&J, AstraZeneca resume trials of COVID-19 vaccines Excelsio Media - comentarios AstraZeneca has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to r… More →
Follow us on social networks!